State Street’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-700,331
| Closed | -$1.03M | – | 5001 |
|
|
2022
Q2 | $1.03M | Sell |
700,331
-2,216,103
| -76% | -$1.63M | ﹤0.01% | 3626 |
|
|
2022
Q1 | $3.35M | Buy |
2,916,434
+1,075,905
| +58% | +$1.75M | ﹤0.01% | 3361 |
|
|
2021
Q4 | $4.6M | Sell |
1,840,529
-4,187,682
| -69% | -$16.5M | ﹤0.01% | 3280 |
|
|
2021
Q3 | $30.9M | Buy |
6,028,211
+432,506
| +8% | +$2.63M | ﹤0.01% | 2157 |
|
|
2021
Q2 | $46.5M | Sell |
5,595,705
-77,149
| -1% | -$650K | ﹤0.01% | 1899 |
|
|
2021
Q1 | $49.4M | Buy |
5,672,854
+1,352,931
| +31% | +$14M | ﹤0.01% | 1758 |
|
|
2020
Q4 | $46.9M | Sell |
4,319,923
-122,490
| -3% | -$1.51M | ﹤0.01% | 1675 |
|
|
2020
Q3 | $53M | Buy |
4,442,413
+620,698
| +16% | +$8.31M | ﹤0.01% | 1424 |
|
|
2020
Q2 | $61.4M | Buy |
3,821,715
+1,326,805
| +53% | +$23.2M | ﹤0.01% | 1303 |
|
|
2020
Q1 | $38.7M | Buy |
2,494,910
+30,834
| +1% | +$662K | ﹤0.01% | 1418 |
|
|
2019
Q4 | $60.6M | Sell |
2,464,076
-392,233
| -14% | -$5.82M | ﹤0.01% | 1384 |
|
|
2019
Q3 | $29.5M | Sell |
2,856,309
-216,025
| -7% | -$2.72M | ﹤0.01% | 1798 |
|
|
2019
Q2 | $38.6M | Buy |
3,072,334
+786,890
| +34% | +$10.1M | ﹤0.01% | 1648 |
|
|
2019
Q1 | $28.3M | Sell |
2,285,444
-287,247
| -11% | -$3.21M | ﹤0.01% | 1818 |
|
|
2018
Q4 | $15.8M | Buy |
2,572,691
+358,154
| +16% | +$2.74M | ﹤0.01% | 2142 |
|
|
2018
Q3 | $23.5M | Buy |
2,214,537
+183,665
| +9% | +$2.1M | ﹤0.01% | 2069 |
|
|
2018
Q2 | $27.5M | Buy |
2,030,872
+231,862
| +13% | +$3.61M | ﹤0.01% | 1907 |
|
|
2018
Q1 | $31.9M | Sell |
1,799,010
-206,454
| -10% | -$3.49M | ﹤0.01% | 1733 |
|
|
2017
Q4 | $25.2M | Buy |
2,005,464
+430,841
| +27% | +$6.26M | ﹤0.01% | 1889 |
|
|
2017
Q3 | $30M | Sell |
1,574,623
-189,827
| -11% | -$2.9M | ﹤0.01% | 1727 |
|
|
2017
Q2 | $26.6M | Buy |
1,764,450
+658,727
| +60% | +$9.96M | ﹤0.01% | 1792 |
|
|
2017
Q1 | $19M | Buy |
1,105,723
+17,088
| +2% | +$228K | ﹤0.01% | 1982 |
|
|
2016
Q4 | $13.2M | Buy |
1,088,635
+359,859
| +49% | +$3.76M | ﹤0.01% | 2193 |
|
|
2016
Q3 | $7.17M | Sell |
728,776
-274,283
| -27% | -$2.5M | ﹤0.01% | 2364 |
|
|
2016
Q2 | $10.3M | Sell |
1,003,059
-24,157
| -2% | -$269K | ﹤0.01% | 2211 |
|
|
2016
Q1 | $12.5M | Buy |
1,027,216
+151,145
| +17% | +$1.53M | ﹤0.01% | 2041 |
|
|
2015
Q4 | $14M | Sell |
876,071
-752,732
| -46% | -$11.2M | ﹤0.01% | 1974 |
|
|
2015
Q3 | $20.9M | Sell |
1,628,803
-45,541
| -3% | -$919K | ﹤0.01% | 1711 |
|
|
2015
Q2 | $40.2M | Buy |
1,674,344
+1,484,595
| +782% | +$28.6M | ﹤0.01% | 1395 |
|
|
2015
Q1 | $3.56M | Buy |
189,749
+17,855
| +10% | +$369K | ﹤0.01% | 2754 |
|
|
2014
Q4 | $3.24M | Sell |
171,894
-523,164
| -75% | -$12.2M | ﹤0.01% | 2797 |
|
|
2014
Q3 | $18.8M | Buy |
695,058
+541,371
| +352% | +$16.8M | ﹤0.01% | 1788 |
|
|
2014
Q2 | $4.78M | Buy |
153,687
+49,298
| +47% | +$1.16M | ﹤0.01% | 2620 |
|
|
2014
Q1 | $2.38M | Buy |
104,389
+25,352
| +32% | +$768K | ﹤0.01% | 2981 |
|
|
2013
Q4 | $1.64M | Buy |
79,037
+5,739
| +8% | +$166K | ﹤0.01% | 3148 |
|
|
2013
Q3 | $2.94M | Buy |
73,298
+14,798
| +25% | +$501K | ﹤0.01% | 2849 |
|
|
2013
Q2 | $1.65M | Buy |
+58,500
| New | +$1.5M | ﹤0.01% | 3063 |
|
Other funds holding EPZM
State Street's EPZM Position: Q3 2022 in Review
State Street sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 700,331 shares — an estimated $1.03M sold.
State Street first reported a position in EPZM in Q2 2013 and held it in 37 quarters. The position peaked at $61.4M in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- State Street reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- State Street sold 700,331 Epizyme, Inc shares in Q3 2022, an estimated $1.03M.
- State Street first reported a position in Epizyme, Inc in Q2 2013 and held it in 37 quarters.
- State Street's Epizyme, Inc position peaked at $61.4M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.